Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Some skin diseases and their treatments can negatively affect male fertility.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Long pulsed Nd: YAG laser is safe and effective for long-term hair reduction in darker skin types.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Hirsutism causes significant psychological distress in women.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Indian Gooseberry has potential for cancer prevention and treatment and promotes hair growth.

3D culture helps maintain hair growth cells better than 2D culture and identifies key genes for potential hair loss treatments.